Vivos Therapeutics Inc. (NASDAQ: VVOS)
$3.1600
-0.0400 ( -2.77% ) 140.1K
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Market Data
Open
$3.1600
Previous close
$3.2000
Volume
140.1K
Market cap
$15.69M
Day range
$3.1100 - $3.4000
52 week range
$1.9100 - $48.7900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 70 | Nov 14, 2024 |
8-k | 8K-related | 14 | Nov 14, 2024 |
def | Proxies and info statements | 4 | Oct 07, 2024 |
8-k | 8K-related | 18 | Sep 20, 2024 |
8-k | 8K-related | 14 | Sep 18, 2024 |
8-k | 8K-related | 13 | Sep 17, 2024 |
8-k | 8K-related | 13 | Sep 12, 2024 |
8-k | 8K-related | 14 | Aug 15, 2024 |
10-q | Quarterly Reports | 84 | Aug 14, 2024 |
10-k/a | Quarterly Reports | 90 | Jul 30, 2024 |